Clinical Trial Update: Hypofractionated Radiotherapy (Stereotactic) Versus Conventional Radiotherapy for Inoperable Early Stage I Non-small Cell Lung Cancer (NSCLC) [Phase 3]

View source ↗

Summary

A Phase 3 trial compares hypofractionated stereotactic radiotherapy with conventional radiotherapy for inoperable early-stage non-small cell lung cancer; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Trans Tasman Radiation Oncology Group | Conditions: Non Small Cell Lung Cancer | Phase 3 | Status: UNKNOWN